We are live on ! Find out more

37 hedge funds and large institutions have $1.02M invested in BioVie in 2025 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 7

5% more capital invested

Capital invested by funds: $968K → $1.02M (+$49.6K)

0.06% more ownership

Funds ownership: 0.54%0.59% (+0.06%)

0% more funds holding

Funds holding: 3737 (0)

0% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 8

Holders
37
Holders Change
Holders Change %
0%
% of All Funds
0.49%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
8
Reduced
8
Closed
7
Calls
Puts
Net Calls
Net Calls Change

BIVI Hedge Fund Activity: Q2 2025 in Review

37 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in BioVie (BIVI) for Q2 2025, worth a combined $1.02M — up 5.1% from $968K a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new BIVI positions and 7 closed out — a net gain of 1 holder — while 8 added to existing stakes and 8 trimmed.

The largest buyer was UBS Group, adding an estimated $71.5K. The largest seller was NewEdge Advisors, cutting an estimated $53.3K.

  • 37 institutional investors held BioVie (BIVI) as of Q2 2025, unchanged from Q1 2025.
  • Funds reported $1.02M of BioVie stock for Q2 2025, up 5.1% quarter-over-quarter.
  • 8 funds opened new BioVie positions in Q2 2025 and 7 closed out, a net change of +1 holder.
  • The largest BioVie buyer in Q2 2025 was UBS Group, an estimated $71.5K added.
  • The largest BioVie seller in Q2 2025 was NewEdge Advisors, an estimated $53.3K sold.

Based on aggregated 13F filings for Q2 2025.